Conference Reports for NATAP

IAS 2025, 13th IAS Conference on HIV Science Kigali, Rwanda July 13-17 Back

MK-8527 Monthly PrEP Phase 3 Studies, In Lactating Women       A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)   https://clinicaltrials.gov/study/NCT06580587   2 phase 3 studies:   A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)   A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)   EXPrESSIVE-10: https://clinicaltrials.gov/study/NCT07071623 EXPrESSIVE-11: https://clinicaltrials.gov/study/NCT07044297